Punctuated Evolution of Prostate Cancer Genomes SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ... Cell 153 (3), 666-677, 2013 | 1466 | 2013 |
A highly specific SpCas9 variant is identified by in vivo screening in yeast A Casini, M Olivieri, G Petris, C Montagna, G Reginato, G Maule, ... Nature biotechnology 36 (3), 265-271, 2018 | 532 | 2018 |
Plasma AR and abiraterone-resistant prostate cancer A Romanel, DG Tandefelt, V Conteduca, A Jayaram, N Casiraghi, ... Science Translational Medicine 7 (312), 312re10-312re10, 2015 | 470 | 2015 |
Tumor clone dynamics in lethal prostate cancer S Carreira, A Romanel, J Goodall, E Grist, R Ferraldeschi, S Miranda, ... Science Translational Medicine 6 (254), 254ra125-254ra125, 2014 | 399 | 2014 |
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ... JAMA Oncology, 2015 | 314 | 2015 |
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution … V Conteduca, D Wetterskog, MTA Sharabiani, E Grande, ... Annals of Oncology, mdx155, 2017 | 280 | 2017 |
A phase II trial of the aurora kinase A inhibitor alisertib for patients with castration resistant and neuroendocrine prostate cancer: efficacy and biomarkers H Beltran, C Oromendia, DC Danila, B Montgomery, C Hoimes, ... Clinical Cancer Research, clincanres. 1912.2018, 2018 | 242 | 2018 |
Comprehensive analysis of genetic ancestry and its molecular correlates in cancer J Carrot-Zhang, N Chambwe, JS Damrauer, TA Knijnenburg, ... Cancer Cell 37 (5), 639-654. e6, 2020 | 221 | 2020 |
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer H Beltran, A Romanel, V Conteduca, N Casiraghi, M Sigouros, ... The Journal of Clinical Investigation 130 (4), 2020 | 168 | 2020 |
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations FW Huang, JM Mosquera, A Garofalo, C Oh, M Baco, A Amin-Mansour, ... Cancer discovery 7 (9), 973-983, 2017 | 126 | 2017 |
The BlenX language: a tutorial L Dematté, C Priami, A Romanel Lecture Notes in Computer Science 5016, 313-365, 2008 | 113 | 2008 |
Unraveling the clonal hierarchy of somatic genomic aberrations D Prandi, SC Baca, A Romanel, CE Barbieri, JM Mosquera, J Fontugne, ... Genome biology 15, 1-16, 2014 | 111 | 2014 |
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit G Petris, A Casini, C Montagna, F Lorenzin, D Prandi, A Romanel, ... Nature Communications 8, 2017 | 107 | 2017 |
The Beta Workbench: a computational tool to study the dynamics of biological systems L Dematté, C Priami, A Romanel Briefings in bioinformatics 9 (5), 437-449, 2008 | 105 | 2008 |
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care H Rennert, K Eng, T Zhang, A Tan, J Xiang, A Romanel, R Kim, W Tam, ... NPJ genomic medicine 1 (1), 1-11, 2016 | 85 | 2016 |
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer G Schaefer, JM Mosquera, R Ramoner, K Park, A Romanel, E Steiner, ... Prostate cancer and prostatic diseases 16 (2), 132-138, 2013 | 85 | 2013 |
ASEQ: fast allele-specific studies from next-generation sequencing data A Romanel, S Lago, D Prandi, A Sboner, F Demichelis BMC medical genomics 8 (1), 9, 2015 | 73 | 2015 |
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC S La Monica, R Minari, D Cretella, L Flammini, C Fumarola, M Bonelli, ... Journal of Experimental & Clinical Cancer Research 38 (1), 222, 2019 | 54 | 2019 |
RB1 Heterogeneity in Advanced Metastatic Castration Resistant Prostate Cancer DN Rodrigues, N Casiraghi, A Romanel, M Crespo, S Miranda, ... Clinical Cancer Research, clincanres. 2068.2018, 2018 | 54* | 2018 |
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes D Liu, JE Shoag, D Poliak, RS Goueli, V Ravikumar, D Redmond, ... Nature communications 11 (1), 1987, 2020 | 51 | 2020 |